CliffBio
small molecule

LEVOTHYROXINE SODIUM

LEVOTHYROXINE SODIUM

Loss of exclusivityDecember 2036latest FDA-listed patent expiry
CompanyFresenius Kabi →View the full company profile on CliffBio

Drug detail

Brand nameLEVOTHYROXINE SODIUM
Active ingredientLEVOTHYROXINE SODIUM
Strength200MCG/5ML (40MCG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalApril 2019
Marketing statusRX

Listed patents

PatentExpiresType
9782376December 2036product
10398669December 2036product
11135190December 2036product

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

LEVOTHYROXINE SODIUM patent cliff — loss of exclusivity December 2036 | CliffBio